Literature DB >> 11509536

Angiotensin-converting enzyme genotype and physical performance during US Army basic training.

L A Sonna1, M A Sharp, J J Knapik, M Cullivan, K C Angel, J F Patton, C M Lilly.   

Abstract

Prior studies have suggested that angiotensin I-converting enzyme (ACE) genotype correlates with superior physical performance in highly selected populations. This study assessed whether such an association exists in a heterogeneous population. Using polymerase chain reaction techniques, we determined the ACE genotypes (insertion/insertion, deletion/insertion, or deletion/deletion) of 62 male and 85 female US Army recruits. Before and after 8 wk of basic training, we determined peak oxygen uptake and performance on the Army Physical Fitness Test (APFT), which includes standardized measures of muscular endurance (sit-ups, push-ups) and a 2-mile run. Subjects of different ACE genotypes had similar peak oxygen uptakes and APFT scores, both before and after training. Subjects with genotype II had higher APFT scores than others, but the differences were not statistically significant. Furthermore, no ACE genotype group had a performance advantage in analyses that adjusted for baseline fitness. We conclude that ACE genotype does not have a strong effect on aerobic power or muscular endurance in healthy, young American adults drawn from an ethnically and geographically diverse population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509536     DOI: 10.1152/jappl.2001.91.3.1355

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

Review 1.  Movement systems as dynamical systems: the functional role of variability and its implications for sports medicine.

Authors:  Keith Davids; Paul Glazier; Duarte Araújo; Roger Bartlett
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Systems modelling of the relationship between training and performance.

Authors:  Tim Taha; Scott G Thomas
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 3.  Association of genetic factors with selected measures of physical performance.

Authors:  William R Thompson; Stuart A Binder-Macleod
Journal:  Phys Ther       Date:  2006-04

Review 4.  Genes, environment and sport performance: why the nature-nurture dualism is no longer relevant.

Authors:  Keith Davids; Joseph Baker
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Olympics: Genetically enhanced Olympics are coming.

Authors:  Juan Enriquez; Steve Gullans
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

Review 6.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

7.  HIF1A P582S gene association with endurance training responses in young women.

Authors:  J S McPhee; J Perez-Schindler; H Degens; D Tomlinson; P Hennis; K Baar; A G Williams
Journal:  Eur J Appl Physiol       Date:  2011-02-23       Impact factor: 3.078

8.  Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Authors:  Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

Review 9.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

10.  Multi-species comparative analysis of the equine ACE gene identifies a highly conserved potential transcription factor binding site in intron 16.

Authors:  Natasha A Hamilton; Imke Tammen; Herman W Raadsma
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.